STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk

Exclusion Criteria

• •Subjects who meet any of the following criteria will be excluded from this study:
• •Subjects with an ocular disease other than glaucoma
• •Subjects participating in a long-term interventional clinical trial
• •Subjects with any other medical condition which would prohibit them from making all study visits within the 24 months
• •Glaucoma patients who have not demonstrated disease progression in the past 3 years
• •Patients with diagnosis of pigmentary dispersion syndrome/glaucoma
• •Patients that have had glaucoma surgery and have IOP ≤ 12 mm Hg
• •Patients with advanced glaucoma with MD ≤ -20 dB
• •Patients with a history of LASIK surgery
• •Patients with myopia \> -6.0 diopters.
• •Patients with hyperopia \>+6.0 diopters.
• •In the investigator's opinion, any patient that cannot satisfactorily complete all of the structural and functional testing included in the protocol (investigator determined)
• •Unable to perform reliable VF testing (Fixation losses 33% or less, false negative rate 33% or less and false positive rate of 15% or less) at the time of study entry
• •In the investigator's opinion, any patient with an ocular disease that could impact study assessments
• •Patients with cataracts in which surgery is planned or anticipated within the next 3 months.
• •Patients with narrow angles in which laser iridotomy is planned or anticipated within the next 3 months.